Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer

Fig. 2

The development of the CRRS model based on the LASSO algorithm. A Ten-fold cross-validations to tune the parameter selection in the LASSO model. The two dotted vertical lines are drawn at the optimal values by minimum criteria (left) and 1 − SE (standard error) criteria (right). B LASSO coefficient profiles of the candidate genes for CRRS construction. C The distribution of risk score, recurrence status, and gene expression panel in four cohort

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us